Researchers at the University of California at Los Angeles have tweaked HIV to create a gene therapy that attacks cancer tumors in mice.
The research is a step forward for the beleaguered field of gene therapy, which has enjoyed isolated successes and suffered repeated setbacks over the past 20 years. But tinkering and fine tuning will be the key to a successful gene therapy, UCLA researchers believe. They published their study in the Feb. 13 issue of Nature Medicine.
The UCLA AIDS Institute scientists genetically altered HIV and folded it into an envelope made of another virus called sindbis, which typically infects insects and birds. That turned the altered HIV into a missile that hunted down metastasized melanoma cells in the lungs of living mice.
"People might wonder if it's scary to use HIV as a therapy," said Irving Chen, who led the UCLA team. "But in actuality we have completely removed 80 percent of the virus. So really it's just a carrier."
Wired